HIV and Coronary Heart Disease Time for a Better Understanding
HIV and Coronary Heart Disease Time for a Better Understanding
复制标题
DOI:
10.1016/j.jacc.2012.06.063
复制
发表时间:
2013-02-05
影响因子:
24
通讯作者:
Cohen, Ariel
中科院分区:
文献类型:
--
作者:
Boccara, Franck;Lang, Sylvie;Cohen, Ariel
Cardiovascular disease, and particularly coronary heart disease, is an emerging area of concern in the HIV population. Since the advent of efficient antiretroviral therapies and the consequent longer patient life span, an increased risk for myocardial infarction has been observed in HIV-infected patients compared with the general population in Western countries. The pathophysiology of this accelerated atherosclerotic process is complex and multifactorial. Traditional cardiovascular risk factors-overrepresented in the HIV population-associated with uncontrolled viral replication and exposure to antiretroviral drugs (per se or through lipid and glucose disturbances) could promote acute ischemic events. Thus, despite successful antiviral therapy, numerous studies suggest a role of chronic inflammation, together with immune activation, that could lead to vascular dysfunction and atherothrombosis. It is time for physicians to prevent coronary heart disease in this high-risk population through the use of tools employed in the general population. Moreover, the lower median age at which acute coronary syndromes occur in HIV-infected patients should shift prevention to include patients